- Home
- XYF vs CVRX Comparison
XYF vs CVRX Comparison
Compare XYF & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XYF | CVRX |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 260.6M | 221.2M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | XYF | CVRX |
|---|---|---|
| Price | $6.37 | $7.95 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $13.17 |
| AVG Volume (30 Days) | ★ 243.0K | 177.7K |
| Earning Date | 11-20-2025 | 02-03-2026 |
| Dividend Yield | ★ 8.45% | N/A |
| EPS Growth | ★ 49.84 | N/A |
| EPS | ★ 5.72 | N/A |
| Revenue | ★ $1,106,908,607.00 | $55,969,000.00 |
| Revenue This Year | N/A | $11.49 |
| Revenue Next Year | N/A | $16.26 |
| P/E Ratio | $1.16 | ★ N/A |
| Revenue Growth | ★ 47.14 | 18.44 |
| 52 Week Low | $6.47 | $4.30 |
| 52 Week High | $20.36 | $18.55 |
Technical Indicators
Market Signals| Indicator | XYF | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 25.26 | 33.16 |
| Support Level | $6.68 | $8.07 |
| Resistance Level | $7.28 | $9.26 |
| Average True Range (ATR) | 0.38 | 0.57 |
| MACD | 0.14 | -0.12 |
| Stochastic Oscillator | 2.70 | 1.45 |
Price Performance
Historical ComparisonAbout XYF X Financial each representing six
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.